Dr. Edgardo Santos' Interview with Heinz-Josef Lenz,MD
Update: 2025-08-25
Description
Interviews with Summit Director Edgardo S. Santos Castillero, MD, FACP, FASCO
NOSCM 2024 | New Orleans Summer Cancer Meeting
Dr. Edgardo Santos' Interview with Heinz-Josef Lenz,MD
Dr. Heinz-Josef Lenz stressed that in metastatic colorectal cancer, initiating treatment with the most potent regimen is key to preventing cross-resistance, using NGS panels and liquid biopsies for rapid biomarker identification. For early-stage disease, he employs genomic signature tests and methylation analyses to predict recurrence—monitoring patients every three months for the first two years—and advocates for more sensitive assays like circulating ethylation to enhance detection.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
